Clinical meaning
Normal bone undergoes continuous remodeling through coordinated osteoclast-mediated resorption and osteoblast-mediated formation. Osteoclasts are multinucleated cells derived from monocyte-macrophage lineage that resorb bone by secreting hydrochloric acid (dissolves hydroxyapatite mineral) and cathepsin K (degrades type I collagen matrix) into a sealed resorption lacuna (Howship lacuna). Osteoblasts then fill the resorption cavity with new osteoid (unmineralized collagen matrix) that subsequently mineralizes. The RANK/RANKL/OPG axis is the master regulatory pathway: osteoblasts express RANK ligand (RANKL), which binds to RANK receptors on osteoclast precursors, stimulating differentiation into mature osteoclasts. Osteoprotegerin (OPG), a decoy receptor produced by osteoblasts, competitively binds RANKL and inhibits osteoclastogenesis. In osteoporosis, an imbalance favoring resorption over formation leads to progressive bone loss — this occurs with estrogen deficiency (postmenopausal), glucocorticoid excess, aging, and hyperparathyroidism. Bisphosphonates are synthetic pyrophosphate analogs with a P-C-P backbone (replacing the P-O-P of pyrophosphate) that resist enzymatic hydrolysis. They bind with high affinity to hydroxyapatite on the bone surface, particularly at sites of active resorption. When osteoclasts ingest bisphosphonate-coated bone, nitrogen-containing bisphosphonates (alendronate, risedronate, ibandronate, zoledronic acid) inhibit farnesyl pyrophosphate synthase (FPPS) in the mevalonate pathway within the osteoclast. This prevents prenylation (lipid modification) of small GTPases (Ras, Rho, Rac) essential for osteoclast cytoskeletal organization, ruffled border formation, and vesicular trafficking, ultimately causing osteoclast apoptosis. The bone-binding affinity and antiresorptive potency differ among agents: zoledronic acid > alendronate > ibandronate > risedronate. Bisphosphonates have extremely long skeletal half-lives (up to 10 years for alendronate) because they become incorporated into the bone matrix and are only released during subsequent remodeling cycles.